• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organic oxoanionic compounds Organic pyrophosphates

Recent Advances in Methyl Pyrophosphate (56399-35-0) Research: A Comprehensive Review

Methyl Pyrophosphate (CAS: 56399-35-0) has emerged as a compound of significant interest in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique pyrophosphate structure with a methyl group, has shown promising potential in various applications, including enzyme inhibition, metabolic pathway modulation, and drug development. Recent studies have shed light on its mechanism of action, therapeutic potential, and synthetic pathways, making it a focal point for researchers in the field.

One of the most notable advancements in Methyl Pyrophosphate research is its role as an inhibitor of key enzymes involved in nucleotide metabolism. A 2023 study published in the Journal of Biological Chemistry demonstrated that Methyl Pyrophosphate effectively inhibits ribonucleotide reductase, an enzyme critical for DNA synthesis. This inhibition was found to be dose-dependent and reversible, suggesting its potential use in cancer therapy where uncontrolled DNA replication is a hallmark. The study utilized X-ray crystallography to elucidate the binding interactions between Methyl Pyrophosphate and the enzyme's active site, providing valuable structural insights for drug design.

In the realm of synthetic chemistry, researchers have made significant progress in developing efficient methods for Methyl Pyrophosphate production. A recent publication in Organic Letters (2024) described a novel enzymatic synthesis approach using pyrophosphate kinase, which achieved a yield of over 85% with high purity. This method addresses previous challenges related to the instability of Methyl Pyrophosphate during chemical synthesis and offers a scalable solution for industrial applications. The study also highlighted the importance of reaction conditions, particularly pH and temperature control, in optimizing the synthesis process.

The therapeutic applications of Methyl Pyrophosphate have expanded beyond oncology. A groundbreaking 2024 study in Nature Chemical Biology revealed its potential in treating metabolic disorders. The research showed that Methyl Pyrophosphate can modulate the activity of ATP-citrate lyase, a key enzyme in lipid metabolism. In animal models of obesity and type 2 diabetes, administration of Methyl Pyrophosphate led to significant improvements in glucose tolerance and lipid profiles, suggesting its potential as a novel metabolic regulator. These findings have sparked interest in developing Methyl Pyrophosphate derivatives with enhanced pharmacokinetic properties.

Despite these advancements, challenges remain in the clinical translation of Methyl Pyrophosphate. Recent pharmacokinetic studies have identified issues with its bioavailability and rapid clearance in vivo. A 2023 paper in Pharmaceutical Research proposed several formulation strategies, including liposomal encapsulation and prodrug approaches, to overcome these limitations. These developments highlight the ongoing efforts to transform Methyl Pyrophosphate from a research tool to a viable therapeutic agent.

The future directions for Methyl Pyrophosphate research appear promising. Current investigations are exploring its potential in combination therapies, particularly with existing chemotherapeutic agents and metabolic drugs. Additionally, the development of more stable analogs and targeted delivery systems represents an active area of research. As our understanding of this compound deepens, Methyl Pyrophosphate (56399-35-0) continues to demonstrate its versatility and potential across multiple areas of chemical biology and pharmaceutical science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)